Comparative Investigations on in Vitro Serum Stability of Polymeric Micelle Formulations

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2011 Sep 1

PMID 21879388

Citations 23

Authors

Tobias Miller

Reinhard Rachel

Ahmed Besheer

Senta Uezguen

Markus Weigandt

Achim Goepferich

Affiliations

Soon will be listed here.

Abstract

Purpose: Stability of polymeric micelles upon injection is essential for a drug delivery system but is not fully understood. We optimized an analytical test allowing quantification of micellar stability in biofluids and applied it to a variety of block copolymer micelles with different hydrophobic block architechtures.

Methods: Polymeric micelles were prepared from four different polymers and investigated via encapsulation of two fluorescent dyes. Samples were incubated in human serum; changes in Foerster Resonance Energy Transfer (FRET) were recorded as a function of time. This fluorescence-based approach was supported semi-quantitatively by results from Asymmetrical Flow Field-Flow-Fractionation (AF4).

Results: After incubation experiments, micellar stability was determined by calculation of two stability-indicating parameters: residual micellar fractions (RMFs) and in vitro serum half-lives. Both parameters showed that PEG-PVPy micelles rapidly destabilized after 3 h (RMF < 45%), whereas PEG-PLA, PEG-PLGA and PEG-PCL micelles were far more stable (RMFs 65 to 98%).

Conclusion: This FRET-based assay is a valuable tool in evaluating and screening serum stability of polymeric micelles and revealed low serum stability of PEG-PVPy micelles compared to polyester-based micelles.

Citing Articles

Enhancing Cancer Therapy: Boron-Rich Polyboronate Ester Micelles for Synergistic Boron Neutron Capture Therapy and PD-1/PD-L1 Checkpoint Blockade.

Chiu Y, Fu W, Huang W, Hsu F, Chen H, Wang T Biomater Res. 2024; 28:0040.

PMID: 38933089 PMC: 11205919. DOI: 10.34133/bmr.0040.

Boron Neutron Capture Therapy Enhanced by Boronate Ester Polymer Micelles: Synthesis, Stability, and Tumor Inhibition Studies.

Fu W, Chiu Y, Huang S, Huang W, Hsu F, Lee H Biomacromolecules. 2024; 25(7):4215-4232.

PMID: 38845149 PMC: 11238341. DOI: 10.1021/acs.biomac.4c00298.

The Use of Lipid-based Nanocarriers to Improve Ovarian Cancer Treatment: An Overview of Recent Developments.

Tantray J, Patel A, Prajapati B, Kosey S, Bhattacharya S Curr Pharm Biotechnol. 2024; 25(17):2200-2217.

PMID: 38357950 DOI: 10.2174/0113892010279572240126052844.

Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence.

Alshawwa S, Kassem A, Farid R, Mostafa S, Labib G Pharmaceutics. 2022; 14(4).

PMID: 35456717 PMC: 9026217. DOI: 10.3390/pharmaceutics14040883.

Affibody Modified G-quadruplex DNA Micelles Incorporating Polymeric 5-Fluorodeoxyuridine for Targeted Delivery of Curcumin to Enhance Synergetic Therapy of HER2 Positive Gastric Cancer.

Zhang C, Fu S, Zhang F, Han M, Wang X, Du J Nanomaterials (Basel). 2022; 12(4).

PMID: 35215023 PMC: 8879187. DOI: 10.3390/nano12040696.

References

Ahyayauch H, Bennouna M, Alonso A, Goni F . Detergent effects on membranes at subsolubilizing concentrations: transmembrane lipid motion, bilayer permeabilization, and vesicle lysis/reassembly are independent phenomena. Langmuir. 2010; 26(10):7307-13. DOI: 10.1021/la904194a. View

Berney C, Danuser G . FRET or no FRET: a quantitative comparison. Biophys J. 2003; 84(6):3992-4010. PMC: 1302980. DOI: 10.1016/S0006-3495(03)75126-1. View

Kim S, Kim D, Shim Y, Bang J, Oh H, Wan Kim S . In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release. 2001; 72(1-3):191-202. DOI: 10.1016/s0168-3659(01)00275-9. View

Greish K . Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Methods Mol Biol. 2010; 624:25-37. DOI: 10.1007/978-1-60761-609-2_3. View

Gaucher G, Marchessault R, Leroux J . Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J Control Release. 2009; 143(1):2-12. DOI: 10.1016/j.jconrel.2009.11.012. View

Theodoly O, Jacquin M, Muller P, Chhun S . Adsorption kinetics of amphiphilic diblock copolymers: from kinetically frozen colloids to macrosurfactants. Langmuir. 2009; 25(2):781-93. DOI: 10.1021/la8030254. View

Montazeri Aliabadi H, Shahin M, Brocks D, Lavasanifar A . Disposition of drugs in block copolymer micelle delivery systems: from discovery to recovery. Clin Pharmacokinet. 2008; 47(10):619-34. DOI: 10.2165/00003088-200847100-00001. View

Montazeri Aliabadi H, Brocks D, Mahdipoor P, Lavasanifar A . A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers. J Control Release. 2007; 122(1):63-70. DOI: 10.1016/j.jconrel.2007.06.008. View

Kim S, Shi Y, Kim J, Park K, Cheng J . Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle-cell interaction. Expert Opin Drug Deliv. 2009; 7(1):49-62. DOI: 10.1517/17425240903380446. View

10.

Toncheva V, Schacht E, Ng S, Barr J, Heller J . Use of block copolymers of poly(ortho esters) and poly (ethylene glycol) micellar carriers as potential tumour targeting systems. J Drug Target. 2003; 11(6):345-53. DOI: 10.1080/10611860310001633839. View

11.

Zheng Z, Obbard J . Evaluation of an elevated non-ionic surfactant critical micelle concentration in a soil/aqueous system. Water Res. 2002; 36(10):2667-72. DOI: 10.1016/s0043-1354(01)00472-9. View

12.

Jones M, Leroux J . Polymeric micelles - a new generation of colloidal drug carriers. Eur J Pharm Biopharm. 1999; 48(2):101-11. DOI: 10.1016/s0939-6411(99)00039-9. View

13.

Chen H, Kim S, He W, Wang H, Low P, Park K . Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo forster resonance energy transfer imaging. Langmuir. 2008; 24(10):5213-7. DOI: 10.1021/la703570m. View

14.

Fraunhofer W, Winter G . The use of asymmetrical flow field-flow fractionation in pharmaceutics and biopharmaceutics. Eur J Pharm Biopharm. 2004; 58(2):369-83. DOI: 10.1016/j.ejpb.2004.03.034. View

15.

Hamaguchi T . [Cancer chemotherapy utilizing nanotechnology]. Gan To Kagaku Ryoho. 2009; 36(3):372-6. View

16.

Savic R, Luo L, Eisenberg A, Maysinger D . Micellar nanocontainers distribute to defined cytoplasmic organelles. Science. 2003; 300(5619):615-8. DOI: 10.1126/science.1078192. View

17.

Adams M, Lavasanifar A, Kwon G . Amphiphilic block copolymers for drug delivery. J Pharm Sci. 2003; 92(7):1343-55. DOI: 10.1002/jps.10397. View

18.

Gref , Luck , Quellec , MARCHAND , Dellacherie , HARNISCH . 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces. 2000; 18(3-4):301-313. DOI: 10.1016/s0927-7765(99)00156-3. View

19.

Chung T, Liu D, Hsieh J, Fan X, Yang J, Chen J . Characterizing poly(epsilon-caprolactone)-b-chitooligosaccharide-b-poly(ethylene glycol) (PCP) copolymer micelles for doxorubicin (DOX) delivery: effects of crosslinked of amine groups. J Nanosci Nanotechnol. 2006; 6(9-10):2902-11. DOI: 10.1166/jnn.2006.450. View

20.

Jacquin M, Muller P, Cottet H, Theodoly O . Self-assembly of charged amphiphilic diblock copolymers with insoluble blocks of decreasing hydrophobicity: from kinetically frozen colloids to macrosurfactants. Langmuir. 2010; 26(24):18681-93. DOI: 10.1021/la103391p. View